Active	Status	Sponsor type	Region	Phase	Filter
5 Active 0 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
KALWAK, Krzysztof
NCT04784455 / 2020-000086-17: Nomacopan (rVA576) in Transplant Associated Thrombotic Microangiopathy	Terminated	3	10	Europe, US	nomacopan (rVA576)	AKARI Therapeutics	Thrombotic Microangiopathies	05/24	05/24
IDUNN, NCT04629833 / 2019-001462-15: Treatment of Steroid-Refractory Acute Graft-versus-host Disease with Mesenchymal Stromal Cells Versus Best Available Therapy	Recruiting	3	210	Europe	MC0518, BAT	medac GmbH	Steroid-refractory Acute Graft-versus-host Disease	08/27	08/30
NCT04785547: ALL SCTped 2012 FORUM Add-on Study Blina Post HSCT	Terminated	2	3	Europe, RoW	Blinatumomab, Blincyto	Prof. Christina Peters, Amgen	ALL, Childhood, Minimal Residual Disease	01/22	01/22
YAJIMA, Julia
No trials found